Park Ha Biological (NASDAQ: BYAH) regains compliance with Nasdaq $1.00 bid rule

Rhea-AI Filing Summary

Park Ha Biological Technology Co., Ltd. reports that it has regained compliance with Nasdaq’s minimum bid price requirement. Nasdaq notified the company that its Class A ordinary shares closed at or above $1.00 per share for 10 consecutive business days from February 20 through March 5, 2026.

Meeting this threshold satisfies Nasdaq Listing Rule 5550(a)(2) for continued listing on the Nasdaq Capital Market, and Nasdaq has closed the matter. This removes the immediate risk that the company’s shares could be delisted for bid-price non-compliance.

Insights

Equity markets and listing standards analyst

Park Ha Bio has cleared Nasdaq’s bid-price deficiency and removed an immediate delisting risk.

The company confirms that Nasdaq now considers it back in compliance with the $1.00 minimum bid price rule after its shares traded at or above that level for 10 consecutive business days ending March 5, 2026. This satisfies Listing Rule 5550(a)(2) for the Nasdaq Capital Market.

Restored compliance means the company continues to meet this specific listing standard, avoiding forced delisting action tied to bid price. Future compliance will still depend on ongoing trading levels, and any renewed drop below the minimum could trigger a new deficiency notice under Nasdaq’s procedures.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of March 2026

Commission File No. 001-42453

PARK HA BIOLOGICAL TECHNOLOGY CO., LTD.

(Translation of registrant’s name into English)

901, Building C
Phase 2, Wuxi International Life Science Innovation Campus
196 Jinghui East Road
Xinwu District, Wuxi, Jiangsu Province
People’s Republic of China 214000 

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F

Form 20-F ☒         Form 40-F ☐

On March 6, 2026, Park Ha Biological Technology Co., Ltd. (the “Company”) received a letter from the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”) stating that because the Company’s Class A ordinary shares had a closing bid price at or above $1.00 per share for 10 consecutive business days, from February 20 through March 5, 2026, the Company had regained compliance with the minimum bid price requirement of $1.00 per share for continued listing on the Nasdaq Capital Market, as set forth in Nasdaq Listing Rule 5550(a)(2), and that the matter is now closed.

1

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Dated: March 6, 2026

	Park Ha Biological Technology Co., Ltd.
	By:	/s/ Xiaoqiu Zhang
	Name:	Xiaoqiu Zhang
	Title:	Chief Executive Officer and Chairperson of the Board

2

FAQ

What did Park Ha Biological Technology Co., Ltd. (BYAH) announce in the latest 6-K?

Park Ha Biological Technology Co., Ltd. announced it has regained compliance with Nasdaq’s minimum bid price rule after its Class A ordinary shares closed at or above $1.00 for 10 consecutive business days, allowing continued listing on the Nasdaq Capital Market under Listing Rule 5550(a)(2).

How did BYAH regain compliance with Nasdaq’s minimum bid price requirement?

BYAH regained compliance because its Class A ordinary shares maintained a closing bid price of at least $1.00 per share for 10 straight business days between February 20 and March 5, 2026, satisfying Nasdaq Listing Rule 5550(a)(2) for continued listing on the Nasdaq Capital Market.

What Nasdaq rule is relevant to Park Ha Biological Technology’s compliance status?

The relevant rule is Nasdaq Listing Rule 5550(a)(2), which requires a minimum $1.00 bid price for continued listing on the Nasdaq Capital Market. BYAH’s Class A ordinary shares met this requirement for 10 consecutive business days, leading Nasdaq to confirm the company’s renewed compliance and close the matter.

What does Nasdaq’s confirmation mean for BYAH’s stock listing?

Nasdaq’s confirmation means BYAH’s Class A ordinary shares currently meet the minimum bid price standard for the Nasdaq Capital Market. With the shares closing at or above $1.00 for 10 consecutive business days, Nasdaq considers the prior bid-price deficiency resolved and has closed the compliance matter.

Over what period did BYAH’s share price meet Nasdaq’s $1.00 minimum bid requirement?

BYAH’s Class A ordinary shares met Nasdaq’s $1.00 minimum bid requirement over 10 consecutive business days from February 20 through March 5, 2026. This continuous compliance period satisfied Nasdaq Listing Rule 5550(a)(2) and led to Nasdaq confirming the company’s continued eligibility for the Nasdaq Capital Market.